Inflammatory bowel disease (IBD) is a debilitating, lifelong condition that changes how people plan their entire lives. In this episode, KT Park, Global Head of Gastroenterology and Hepatology, and Seppi Lin, Head of OMNI Early Clinical Development, explore the complex biology behind IBD. They discuss the role of genetics, the gut microbiome, and an individual’s environment, as well as the exciting future of "immune reset" therapies that could offer hope for people with IBD.

Read the full text transcript at www.gene.com/stories/the-abcs-of-ibd

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Genentech. Innehållet i podden är skapat av Genentech och inte av, eller tillsammans med, Poddtoppen.